Originally developed for type 2 diabetes, it has proven effective in promoting weight loss and is now approved for this purpose as well
NP2Go, founded and led by nurse practitioners, provides access to GLP-1 therapies such as compounded Semaglutide for patients in rural and underserved areas
Common effects include nausea, vomiting, and low blood sugar
Semaglutide GLP-1 is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the natural hormone GLP-1, which is crucial for regulating blood sugar and appetite
According to a large, randomized controlled study, at the maximum dose of Ozempic for weight loss, obese patients lost an average of 6% of their body weight at week 12, 12% at week 28, and 15% at week 68